Emerging proteins involved in castration-resistant prostate cancer via the AR-dependent and AR-independent pathways (Review)

Despite achieving optimal initial responses to androgen deprivation therapy, most patients with prostate cancer eventually progress to a poor prognosis state known as castration-resistant prostate cancer (CRPC). Currently, there is a notable absence of reliable early warning biomarkers and effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Kangle, Liu, Chunhua, Wang, Weixi, Kong, Piaoping, Tao, Zhihua, Liu, Weiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609492/
https://www.ncbi.nlm.nih.gov/pubmed/37732538
http://dx.doi.org/10.3892/ijo.2023.5575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609492/
https://www.ncbi.nlm.nih.gov/pubmed/37732538
http://dx.doi.org/10.3892/ijo.2023.5575

Ejemplares similares